TP53 and colorectal carcinoma: In vitro studies also revealed directly that ATIC KD significantly repressed the proliferation of human CRC cells which reduced ATIC enzyme activity and ATP levels (Figs. S6l and S6m) with the effects again being more pronounced in p53−/− cells.